CONTENTS:
- The presence of new psychoactive substances in a Tor Network marketplace environment. Dolliver D.S., Kuhns J.B., p. 321-329.
- Do you get what you paid for? An examination of products advertised as kratom. Griffin O.H., 3rd, Daniels J.A., Gardner E.A., p. 330-335.
- Patterns of use, acute subjective experiences, and motivations for using synthetic cathinones ("bath salts") in recreational users. Ashrafioun L., Bonadio F.A., Baik K.D., Bradbury S.L., Carhart V.L., Cross N.A., et al., p. 336-343.
- The associations of naturalistic classic psychedelic use, mystical experience, and creative problem solving. Sweat N.W., Bates L.W., Hendricks P.S., p. 344-350.
- A case of 3,4-dimethoxyamphetamine (3,4-DMA) and 3,4-methylenedioxymethamphetamine (MDMA) toxicity with possible metabolic interaction. Darracq M.A., Thornton S.L., Minns A.B., Gerona R.R., p. 351-354.
- A case of acute pericarditis following intravenous injection of crushed morphine tablets. Anderson R.J., Corbett B., Ly B.T., p. 355-358.
- Is general or alcohol-specific perceived social support associated with depression among adults in substance use treatment? Shorey R.C., Dawson A.E., Haynes E., Strauss C., Elmquist J., Anderson S., et al., p. 359-368.
- Association of traffic injuries, substance use disorders, and ED visit outcomes among individuals aged 50+years. Choi N.G., DiNitto D.M., Marti C.N., Choi B.Y., p. 369-376.
- Racial and ethnic differences in substance use diagnoses, comorbid psychiatric disorders, and treatment initiation among HIV-positive and HIV-negative women in an integrated health plan. Storholm E.D., Silverberg M.J., Satre D.D., p. 377-383.
- Personality and defense styles: Clinical specificities and predictive factors of alcohol use disorder in women. Ribadier A., Dorard G., Varescon I., p. 384-392.
- Drug initiation of female detainees in a compulsory drug treatment institution in China. Liu L., Hsiao S.C., Kaplan C., p. 393-401.